Stemcell United Limited has announced that it plans to undertake a rights issue and a private placement to raise in aggregate of up to $2.3 million to provide capital for developing the Company’s business.
The rights issue will be made to all existing shareholders on the basis of one new ordinary share for each existing five ordinary shares held on the Record Date at a price of $0.02 for each new ordinary share. The rights issue will be non-renounceable, and the new shares will rank pari passu in all respects with the Company’s existing shares. The Company is discussing with various underwriters on underwriting of the rights issue.
The Company plans to lodge an Offer document and related documentation with ASX not later than 15 January 2018, at which time the timetable for the rights issue will also be announced.
In addition, it is intended that a private placement of up to 30 million shares will be made to sophisticated investors at a price of $0.02 per share to raise up to $600,000. The placement Shares will rank pari passu in all respects with existing shares.
The rights issue and share placement will significantly strengthen SCU’s financial position, with the capital to be used to fund its business plan.
The company will seek shareholder approval if the issue of the placement shares exceeds its 15% capacity under Listing rule 7.1. The issue will not be to a class of security holder.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.